Pro Dex INC 10-Q quarterly reports

Pro-Dex, Inc. reported significantly increased net income and cash flow for the second quarter and first half of fiscal 2026, driven by the sale of its Monogram Technologies investment and robust orthopedic product sales.

Pro-Dex, Inc. reported a significant increase in net sales and net income for the first quarter of fiscal 2026, driven by strong orthopedic medical device sales and an unrealized gain on investments.

Pro-Dex Inc. announces increased net sales and profitability for the third quarter of fiscal year 2025, driven by growth in medical device sales and repair revenue.

Pro-Dex Inc. announces increased revenue and profitability for Q2 2025, primarily driven by strong growth in orthopedic medical device sales.

Pro-Dex Inc. reports a significant increase in revenue and profitability for the first quarter of fiscal year 2025, primarily driven by strong medical device sales.

Pro-Dex Inc. saw a revenue increase in Q3 2024 compared to the same period last year, but experienced a decrease in net income due to various factors including unrealized losses on investments.

Pro-Dex, Inc. saw a revenue increase in the second quarter of fiscal year 2024, but reported a net loss due to unrealized losses on investments and increased operating expenses.